Tag:

Sanofi

Latest Headlines

Latest Headlines

UPDATED: Sanofi-backed MyoKardia nabs a $46M round for cardio pipeline construction

Sanofi partner MyoKardia is getting a fresh injection of capital, garnering $46 million in its Series B as the South San Francisco-based biotech plots the next stage of its clinical journey developing new drugs for genetically defined groups of heart patients.

Lantus dragged down diabetes, but Sanofi beat on sales, earnings anyway

Sanofi beat expectations for sales and earnings this quarter. Both grew, even without an extra bounce from exchange rates. And for once, the diabetes blockbuster Lantus wasn't driving the caravan.

Ex-Sanofi exec Whitaker lands at Valeant in EVP role

After departing from Sanofi last year for the CEO's chair at Synta Pharmaceuticals, Anne Whitaker is now moving on to Valeant, where she'll step into the role of EVP and group chairman.

Sanofi dumps an ImmunoGen cancer drug as it scales back in oncology

Sanofi is again trimming its oncology pipeline, walking away from an armed-antibody cancer treatment licensed from ImmunoGen as it reshapes its approach to the field.

Alnylam's star RNAi drug keeps the pace on the way to Phase III

Alnylam's lead RNAi treatment continued to prevent nerve damage tied to a rare disease in an ongoing Phase II study, paving the path for late-stage development.

Sanofi sues drug information startup over side effect info

Sanofi is suing startup Diagnosia over the publication of information about side effects and drug interactions in its physician decision support software.

Sanofi and Innate Pharma team up on anticancer ADCs

Sanofi has reached out to its French neighbor Innate Pharma to collaborate on armed antibody treatments, borrowing the biotech's technology to craft new treatments for cancer and inflammatory disease.

Sanofi expands PA vaccine facility to prepare for dengue launch

Sanofi plans to manufacture its highly anticipated dengue vaccine in a French facility built specifically for the product. But Sanofi Pasteur's vaccine operation in Swiftwater, PA, is also expanding in preparation for a launch of the vax, which may happen later this year.

Careful, European drugmakers. Fitch says M&A may be a bit too heated

Fitch Ratings is raising the flag on pharma M&A. The credit ratings agency says the current spate of dealmaking is putting some pressure on European Big Pharma players.

Sanofi Pasteur U.S. operation part of dengue vaccine buildup

Sanofi's highly anticipated dengue vaccine is being manufactured in a facility in France built specifically for the product. But expansion is also going on at Sanofi Pasteur's vaccine operation in Swiftwater, PA, in preparation for a launch of the vax which may happen later this year.